Cargando…

Impact of 8-week linoleic acid intake in soy oil on Lp-PLA(2) activity in healthy adults

BACKGROUND: No intervention follow-up study has examined the association between plasma n-6 polyunsaturated fatty acids (PUFAs) and lipoprotein-associated phospholipase A(2) (Lp-PLA(2)), which is a risk factor for cardiovascular disease (CVD). We aimed to determine whether the administration of lino...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Minkyung, Kim, Minjoo, Lee, Ayoung, Yoo, Hye Jin, Her, Jung Soo, Jee, Sun Ha, Lee, Jong Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422895/ https://www.ncbi.nlm.nih.gov/pubmed/28503188 http://dx.doi.org/10.1186/s12986-017-0186-2

Ejemplares similares

Effect of weight loss on circulating fatty acid profiles in overweight subjects with high visceral fat area: a 12-week randomized controlled trial
por: Lee, Young Ju, et al.
Publicado: (2018)

Prehypertension-Associated Elevation in Circulating Lysophosphatidlycholines, Lp-PLA(2) Activity, and Oxidative Stress
por: Kim, Minjoo, et al.
Publicado: (2014)

Effects of overweight and the PLA2G7 V279F polymorphism on the association of age with systolic blood pressure
por: Kim, Minjoo, et al.
Publicado: (2017)

Association between increased visceral fat area and alterations in plasma fatty acid profile in overweight subjects: a cross-sectional study
por: Kang, Miso, et al.
Publicado: (2017)

Lp-PLA2 Inhibition—The Atherosclerosis Panacea?
por: Karakas, Mahir, et al.
Publicado: (2010)

Natural Killer Cell Activity and Interleukin-12 in Metabolically Healthy versus Metabolically Unhealthy Overweight Individuals
por: Kim, Minjoo, et al.
Publicado: (2017)

Corrigendum: Natural Killer Cell Activity and Interleukin-12 in Metabolically Healthy versus Metabolically Unhealthy Overweight Individuals
por: Kim, Minjoo, et al.
Publicado: (2018)

Lp-PLA(2) Inhibitors for the Reduction of Cardiovascular Events
por: Steen, Dylan L., et al.
Publicado: (2013)

Lp-PLA2 levels in HIV-infected patients
por: Díaz-Pollán, Beatriz, et al.
Publicado: (2014)

Genetic invalidation of Lp-PLA(2) as a therapeutic target: Large-scale study of five functional Lp-PLA(2)-lowering alleles
por: Gregson, John M, et al.
Publicado: (2016)

Liver Cirrhosis Patients Who Had Normal Liver Function Before Liver Cirrhosis Development Have the Altered Metabolic Profiles Before the Disease Occurrence Compared to Healthy Controls
por: Yoo, Hye Jin, et al.
Publicado: (2019)

The Relationship between Intracarotid Plaque Neovascularization and Lp (a) and Lp-PLA2 in Elderly Patients with Carotid Plaque Stenosis
por: Sun, Chang, et al.
Publicado: (2022)

Genetic risk score of common genetic variants for impaired fasting glucose and newly diagnosed type 2 diabetes influences oxidative stress
por: Kim, Minjoo, et al.
Publicado: (2018)

Association Lp-PLA2 Gene Polymorphisms with Coronary Heart Disease
por: Ma, Sha, et al.
Publicado: (2022)

Circulating and PBMC Lp-PLA(2) Associate Differently with Oxidative Stress and Subclinical Inflammation in Nonobese Women (Menopausal Status)
por: Paik, Jean Kyung, et al.
Publicado: (2012)

Carriage of the V279F Null Allele within the Gene Encoding Lp-PLA(2) Is Protective from Coronary Artery Disease in South Korean Males
por: Jang, Yangsoo, et al.
Publicado: (2011)

Associations between hypertension and the peroxisome proliferator-activated receptor-δ (PPARD) gene rs7770619 C>T polymorphism in a Korean population
por: Kim, Minjoo, et al.
Publicado: (2018)

Metabolomics identifies increases in the acylcarnitine profiles in the plasma of overweight subjects in response to mild weight loss: a randomized, controlled design study
por: Kang, Miso, et al.
Publicado: (2018)

Effects and potential mechanism of atorvastatin treatment on Lp-PLA2 in rats with dyslipidemia
por: Zheng, Dongdan, et al.
Publicado: (2017)

Lp-PLA(2), a new biomarker of vascular disorders in metabolic diseases
por: De Stefano, Alessandro, et al.
Publicado: (2019)

Association between Lp-PLA2 and coronary heart disease in Chinese patients
por: Yang, Li, et al.
Publicado: (2017)

The changes of Lp-PLA2 in patients with gestational diabetes and its clinical significance
por: Wang, Guo-Hua, et al.
Publicado: (2021)

Homocysteine and Lp-PLA2 levels: Diagnostic value in coronary heart disease
por: Wu, Linlin, et al.
Publicado: (2023)

Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids
por: Jackisch, Laura, et al.
Publicado: (2018)

Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis
por: Deng, Mingming, et al.
Publicado: (2021)

Age-Specific Determinants of Pulse Wave Velocity among Metabolic Syndrome Components, Inflammatory Markers, and Oxidative Stress
por: Kim, Minkyung, et al.
Publicado: (2018)

Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality
por: Fan, Yahui, et al.
Publicado: (2022)

The peptidylglycine-α-amidating monooxygenase (PAM) gene rs13175330 A>G polymorphism is associated with hypertension in a Korean population
por: Yoo, Hye Jin, et al.
Publicado: (2017)

Genome-Wide Association Study of Lp-PLA(2) Activity and Mass in the Framingham Heart Study
por: Suchindran, Sunil, et al.
Publicado: (2010)

Association of Lp-PLA(2) Mass and Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients
por: Wang, Yan, et al.
Publicado: (2015)

Lp-PLA(2) activity and mass and CRP are associated with incident symptomatic peripheral arterial disease
por: Fatemi, Shahab, et al.
Publicado: (2019)

On the present and future role of Lp-PLA(2) in atherosclerosis-related cardiovascular risk prediction and management
por: Fras, Zlatko, et al.
Publicado: (2020)

Sequencing of Lp-PLA2-encoding PLA2G7 gene in 2000 Europeans reveals several rare loss-of-function mutations
por: Song, K, et al.
Publicado: (2012)

A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients
por: Kim, Minjoo, et al.
Publicado: (2017)

EPHA6 rs4857055 C > T polymorphism associates with hypertension through triglyceride and LDL particle size in the Korean population
por: Kim, Minjoo, et al.
Publicado: (2017)

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A(2 )(Lp-PLA(2 )): a review
por: Silva, Isis T, et al.
Publicado: (2011)

Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement
por: Zheng, Dongdan, et al.
Publicado: (2014)

Lp‐PLA(2), Plaque Inflammation and Lesion Development Vary Fundamentally Between Different Vascular Sites
por: Marsche, Gunther
Publicado: (2015)

Lp-PLA2 as a biomarker and its possible associations with SARS-CoV-2 infection
por: Dua, Pamila, et al.
Publicado: (2022)

The association between circulating Hcy and Lp-PLA2 levels and poststroke depression: A meta-analysis
por: Tao, Yongjun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qp9bq4i5o7u7d3uc8rkbeu8m3a